Control of Cross Talk between Angiogenesis and Inflammation by Mesenchymal Stem Cells for the Treatment of Ocular Surface Diseases
Angiogenesis is beneficial in the treatment of ischemic heart disease and peripheral artery disease. However, it facilitates inflammatory cell filtration and inflammation cascade that disrupt the immune and angiogenesis privilege of the avascular cornea, resulting in ocular surface diseases and even...
Saved in:
Main Authors: | Fei Li, Shao-zhen Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/7961816 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross Talk between Inflammation and Metabolic Disorders
by: Jie Chen, et al.
Published: (2022-01-01) -
Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
by: Kenichi Kimoto, et al.
Published: (2012-01-01) -
MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction
by: Teng Ma, et al.
Published: (2018-01-01) -
Ocular Inflammation
by: Valentín Huerva, et al.
Published: (2015-01-01) -
Olfactory mucosa-mesenchymal stem cells with overexpressed Nrf2 modulate angiogenesis and exert anti-inflammation effect in an in vitro traumatic brain injury model
by: Zigui Chen, et al.
Published: (2025-02-01)